In vitro PK/PD modeling of tyrosine kinase inhibitors in non‐small cell lung cancer cell lines

Documenti analoghi

• Baseline multi‐omics signatures could predict therapeutic response to neoadjuvant anti‐PD‐1 immunochemotherapy in non‐small‐cell lung cancer
  di: Ailing Cao, et al.
  Pubblicazione: (2026)
• Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study
  di: Pulin Li, et al.
  Pubblicazione: (2024)
• Single‐cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer
  di: Xiaoshen Zhang, et al.
  Pubblicazione: (2024)
• The co‐location of CD14+APOE+ cells and MMP7+ tumour cells contributed to worse immunotherapy response in non‐small cell lung cancer
  di: Guangyu Fan, et al.
  Pubblicazione: (2024)
• CXCR5 and TLR4 signals synergistically enhance non‐small cell lung cancer progression
  di: Ji Hye Shin, et al.
  Pubblicazione: (2024)